In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

Initial public offerings (IPOs) have started to pick up steam across the medtech industry over the past couple of years.

The new CEO will replace Stanley Bergman, who announced his retirement in July after 45 years with Henry Schein.

Philips (NYSE: PHG) operates in a wide range of spaces as one of the largest companies in the world, including Connected Care ...

Fresenius Medical Care, a major provider of renal disease products, will start the new year with a new global chief medical ...

Makatsaria and LivaNova’s leadership outlined the company’s plan for growth during a November Investor Day event. He spoke to ...

Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...

Affluent Medical recently announced agreements to acquire Caranx Medical and Artedrone to form a new medtech company called ...

Picard Medical (NYSE:PMI) announced today that it entered into a definitive agreement for a private placement financing of up ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

Boston Scientific (NYSE:BSX) will have a transition at the top of its Cardiac Rhythm Management & Diagnostics (CRMDx) ...

Solventum (NYSE:SOLV) announced today that it completed its previously announced acquisition of Acera Surgical.